You are using an older browser version. Please use a supported version for the best MSN experience.

Glenmark sets up new biologicals plant in Switzerland

LiveMint logoLiveMint 04-06-2014 C.H. Unnikrishnan

Mumbai: Glenmark Pharmaceuticals SA, a unit of drugmaker Glenmark Pharmaceuticals Ltd, said on Wednesday that it has opened a new monoclonal antibody manufacturing facility at La Chaux-de-Fonds in Switzerland.

This facility is compliant with international regulatory standards and will supplement Glenmark’s existing in-house discovery and development capabilities and supply material for clinical development. The investment in the new plant and its production capacity was not disclosed.

“This manufacturing facility has been designed for use of single use bioreactor systems and also houses a suite for manufacturing cell banks,” Glenmark said in a statement on Wednesday .

More From LiveMint

image beaconimage beaconimage beacon